Apeloa Pharmaceutical Co.,Ltd (000739.SZ)
CNY 13.57
(1.12%)
CNY 13.57
(1.12%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 11.47 Billion | 10.54 Billion | 8.94 Billion | 7.87 Billion | 7.21 Billion | 6.37 Billion |
| Cost of Revenue | 8.62 Billion | 8.02 Billion | 6.56 Billion | 5.67 Billion | 4.87 Billion | 4.34 Billion |
| Gross Profit | 2.85 Billion | 2.52 Billion | 2.37 Billion | 2.2 Billion | 2.33 Billion | 2.03 Billion |
| Operating Expenses | 1.63 Billion | 1.45 Billion | 1.28 Billion | 1.25 Billion | 1.6 Billion | 1.51 Billion |
| Selling, General and Administrative Expenses | 1.06 Billion | 609.96 Million | 576.43 Million | 684.28 Million | 978.82 Million | 971.3 Million |
| Research and Development Expenses | 624.87 Million | 532.91 Million | 446.21 Million | 350.05 Million | 359.89 Million | 269.65 Million |
| Other Expenses | -58.95 Million | 313.22 Million | 264.68 Million | 216.9 Million | 269.63 Million | -30.82 Million |
| Cost and Expenses | 10.25 Billion | 9.48 Billion | 7.85 Billion | 6.92 Billion | 6.48 Billion | 5.85 Billion |
| Operating Income | 1.22 Billion | 1.01 Billion | 1.11 Billion | 969.7 Million | 644.15 Million | 490.53 Million |
| Interest Expense | 37.69 Million | 59.23 Million | 35.72 Million | 16.01 Million | 30.15 Million | 42 Million |
| Income Tax Expense | 149.33 Million | 22.89 Million | 158.52 Million | 144.42 Million | 80.32 Million | 91.63 Million |
| Earnings before Tax | 1.2 Billion | 1.01 Billion | 1.11 Billion | 961.15 Million | 633.72 Million | 462.19 Million |
| Net Income | 1.05 Billion | 989.17 Million | 955.55 Million | 816.73 Million | 553.4 Million | 370.56 Million |
| Earnings Per Share Basic | 0.90 | 0.85 | 0.81 | 0.69 | 0.47 | 0.31 |
| Earnings Per Share Diluted | 0.90 | 0.85 | 0.81 | 0.69 | 0.47 | 0.31 |
| Weighted Average Shares Outstanding | 1.16 Billion | 1.16 Billion | 1.17 Billion | 1.17 Billion | 1.17 Billion | 1.17 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.16 Billion | 1.16 Billion | 1.17 Billion | 1.17 Billion | 1.17 Billion | 1.17 Billion |
| Gross Margin | 0.25 | 0.24 | 0.27 | 0.28 | 0.32 | 0.32 |
| EBIT Margin | 0.16 | 0.15 | 0.18 | 0.17 | 0.15 | 0.14 |
| Profit Margin | 0.09 | 0.09 | 0.11 | 0.10 | 0.08 | 0.06 |
| EBITDA | 1.79 Billion | 1.46 Billion | 1.5 Billion | 1.27 Billion | 1.01 Billion | 819.66 Million |
| Earnings Before Tax Margin | 0.11 | 0.10 | 0.13 | 0.12 | 0.09 | 0.08 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 2.86 Billion | 3.21 Billion | 3.19 Billion | 2.95 Billion | 11.41 Billion | 2.54 Billion |
| Cost of Revenue | 2.19 Billion | 2.45 Billion | 2.42 Billion | 2.34 Billion | 8.68 Billion | 1.85 Billion |
| Gross Profit | 663.2 Million | 759.11 Million | 768.94 Million | 614.44 Million | 2.73 Billion | 692.49 Million |
| Operating Expenses | 384.91 Million | 399.33 Million | 414.06 Million | 491.75 Million | 1.64 Billion | 382.66 Million |
| Selling, General and Administrative Expenses | 515.98 Million | 221.68 Million | 275.88 Million | 336.54 Million | - | 478.16 Million |
| Research and Development Expenses | 152.43 Million | 138.65 Million | 152.93 Million | 123.51 Million | - | 131.96 Million |
| Other Expenses | -283.5 Million | -38.99 Million | -808.41 Thousand | -31.68 Million | -42 Million | -7.25 Million |
| Cost and Expenses | 2.58 Billion | 2.85 Billion | 2.84 Billion | 2.83 Billion | 10.33 Billion | 2.23 Billion |
| Operating Income | 282.67 Million | 359.78 Million | 300.29 Million | 122.69 Million | 1.08 Billion | 304.59 Million |
| Interest Expense | 7.22 Million | 7.01 Million | 8.42 Million | 6.71 Million | 47.23 Million | 2.73 Million |
| Income Tax Expense | 36.59 Million | 58.08 Million | 55.77 Million | -4.04 Million | 149.33 Million | 47.06 Million |
| Earnings before Tax | 281.34 Million | 436.64 Million | 299.48 Million | 197.05 Million | 1.2 Billion | 297.33 Million |
| Net Income | 244.8 Million | 381.12 Million | 243.71 Million | 203.99 Million | 1.05 Billion | 250.27 Million |
| Earnings Per Share Basic | 0.21 | 0.33 | 0.21 | 0.17 | - | 0.21 |
| Earnings Per Share Diluted | 0.21 | 0.33 | 0.21 | 0.17 | - | 0.21 |
| Weighted Average Shares Outstanding | 1.15 Billion | 1.15 Billion | 1.16 Billion | 1.16 Billion | 1.16 Billion | 1.16 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.15 Billion | 1.15 Billion | 1.16 Billion | 1.16 Billion | 1.16 Billion | 1.16 Billion |
| Gross Margin | 0.23 | 0.24 | 0.24 | 0.21 | 0.24 | 0.27 |
| EBIT Margin | 0.10 | 0.16 | 0.11 | 0.09 | - | 0.13 |
| Profit Margin | 0.09 | 0.12 | 0.08 | 0.07 | 0.09 | 0.10 |
| EBITDA | 288.56 Million | 503.44 Million | 364.09 Million | 260.52 Million | - | 321.49 Million |
| Earnings Before Tax Margin | 0.10 | 0.11 | 0.09 | 0.04 | 0.09 | 0.12 |
EXICOM
HLG
RKDL
603337
SVT
LOCO